A June to July 2023 survey using the WHO and Health Action International method found essential medicines in stock in 52.6% of public health facilities on average, with the lowest availability in Batha, Kanem, Lac and Hadjer Lamis.
Published as "National availability, prices and affordability of essential medicines: a comprehensive analysis using WHO/HAI methodology in Chad". A descriptive cross-sectional study of public, private and contracted (religious) outlets, carried out from 1 June to 31 July 2023 by WHO's Chad office with staff of the General Directorate of Pharmacy, Medicines and Laboratories. Availability was the share of surveyed outlets holding each medicine, and prices were expressed as median price ratios. The introduction describes the regulatory system: the Directorate acts as the national regulator, the authors rate its maturity at level 1 on a scale of 1 to 4, and the country has no medicines manufacturer. It was the first such survey in Chad since 2004.
The survey covers essential medicines in general, not cancer medicines, but it shows the supply system cancer care in Chad depends on: about half of listed medicines in stock in public facilities, and generics far cheaper than brands.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/